1. Differences and similarities between coronary atherosclerosis and ischaemic heart disease: implications for cardiac imaging

   • Gianmario Sambuceti

   Editorial 23 February 2005 Pages: 385 - 388

2. Dual-phase ¹⁸F-fluoro-2-deoxy-d-glucose positron emission tomography as a prognostic parameter in patients with pancreatic cancer

   • Andrej Lyshchik
   • Tatsuya Higashi
   • Tsuneo Saga

   Original Article 15 September 2004 Pages: 389 - 397

   

3. PET: too much of a good thing? Does the plethora of choices impact on patient management?

   • Chaitanya Divgi
   • Neeta Pandit-Taskar

   Editorial Commentary 11 March 2005 Pages: 398 - 398

4. FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis

   • Mariëtte CA van Kouwen
   • Jan B.M.J. Jansen
   • Joost P.H. Drenth

   Original Article 12 November 2004 Pages: 399 - 404

   

5. In vivo imaging of adenosine A_2A receptors in rat and primate brain using [¹¹C]SCH442416

   • R. M. Moresco
   • S. Todde
   • F. Fazio

   Original Article 10 November 2004 Pages: 405 - 413

   

6. Diagnosis of Alzheimer’s disease using brain perfusion SPECT and MR imaging: which modality achieves better diagnostic accuracy?

   • Takao Kubota
   • Yo Ushijima
   • Tsunehiko Nishimura

   Original Article 20 November 2004 Pages: 414 - 421

   

7. O-(2-[¹⁸F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours

   • M. Weckesser
   • K.J. Langen
   • O. Schober

   Original Article 14 January 2005 Pages: 422 - 429

   

8. Survival benefit after revascularization is independent of left ventricular ejection fraction improvement in patients with previous myocardial infarction and viable myocardium

   • Wanda Acampa
   • Mario Petretta
   • Alberto Cuocolo

   Original Article 20 November 2004 Pages: 430 - 437

   

9. Influence of the polyol pathway on norepinephrine transporter reduction in diabetic cardiac sympathetic nerves: implications for heterogeneous accumulation of MIBG

   • Yasushi Kiyono
   • Satomi Kajiyama
   • Hideo Saji

   Original Article 26 November 2004 Pages: 438 - 442

   

10. Myocardial β-adrenoceptor downregulation in idiopathic dilated cardiomyopathy measured in vivo with PET using the new radioligand (S)-[¹¹C]CGP12388

    • Richard M. de Jong
    • Antoon T. M. Willemsen
    • Philip H. Elsinga

    Original Article 11 December 2004 Pages: 443 - 447

    

11. Hyperpolarised ³He MRI and ^81mKr SPECT in chronic obstructive pulmonary disease

    • Trine Stavngaard
    • Lise Vejby Søgaard
    • Asger Dirksen

    Original Article 20 November 2004 Pages: 448 - 457

    

12. Validation of prospective whole-body bone marrow dosimetry by SPECT/CT multimodality imaging in ¹³¹I-anti-CD20 rituximab radioimmunotherapy of non-Hodgkin’s lymphoma

    • Jan A. Boucek
    • J. Harvey Turner

    Original Article 20 November 2004 Pages: 458 - 469

    

13. In vivo biodistribution and pharmacokinetics of ¹⁸F-labelled Spiegelmers: a new class of oligonucleotidic radiopharmaceuticals

    • Raphaël Boisgard
    • Bertrand Kuhnast
    • Bertrand Tavitian

    Original Article 22 December 2004 Pages: 470 - 477

    

14. Radiolabelling DOTA-peptides with ⁶⁸Ga

    • Wouter A. P. Breeman
    • Marion de Jong
    • Eric P. Krenning

    Occasional Survey 18 January 2005 Pages: 478 - 485

    

15. Brain glucose metabolism in the early and specific diagnosis of Alzheimer’s disease

    • Lisa Mosconi

    Review Article 04 March 2005 Pages: 486 - 510

    

16. Pre-therapeutic dosimetry with radiolabelled somatostatin analogues in patients with advanced neuroendocrine tumours

    • F. Forrer
    • J. Mueller-Brand
    • H. Maecke

    Letter to the Editor 02 February 2005 Pages: 511 - 512

17. Reply

    • A. Helisch
    • P. Bartenstein

    Letter to the Editor 02 February 2005 Pages: 513 - 513

18. ¹¹C-methionine PET versus ^99mTc-sestamibi in the pre-operative localisation of hyperfunctional parathyroid tissue

    • Theodoros Athanasoulis

    Letter to the Editor 18 January 2005 Pages: 514 - 514

19. Reply

    • Anne-Rose Boerner

    Letter to the Editor 18 January 2005 Pages: 515 - 515

20. Heterogeneity of cerebral blood flow in dementia

    • Jyrki T. Kuikka

    Letter to the Editor 05 March 2005 Pages: 516 - 516

    

21. Visualisation of impaired dopamine biosynthesis in a case of aromatic l-amino acid decarboxylase deficiency by co-registered ¹⁸F-FDOPA PET and magnetic resonance imaging

    • Hung-Jen Hsieh
    • Sheng-Hsiang Lin
    • Hon-Man Liu

    Image of the Month 12 October 2004 Pages: 517 - 517

    

22. The detection of aortic valve infection by FDG-PET/CT in a patient with infection following total knee replacement

    • O. Belohlavek
    • J. Votrubova
    • P. Fencl

    Image of the Month 10 November 2004 Pages: 518 - 518

    

23. Is amyloid plaque imaging the key to monitoring brain pathology of Alzheimer’s disease in vivo?

    • John Hardy
    • Agneta Nordberg

    Erratum 04 March 2005 Pages: 519 - 519

24. Myocardial metabolism of ¹²³I-BMIPP under low-dose dobutamine infusion: implications for clinical SPECT imaging of ischemic heart disease

    • Ryohei Hosokawa
    • Ryuji Nohara
    • Toru Kita

    Erratum 18 March 2005 Pages: 520 - 520

25. First EANM learning course on clinical PET in Russian Language

    Blue pages 31 March 2005 Pages: B7 - B8

26. 30th SEMINAR European School of Nuclear Medicine

    Blue pages 31 March 2005 Pages: B9 - B9